锦欣生殖医疗集团有限公司（股票代码：01951）于2026年6月23日发布翌日披露报表，公告其在香港联交所场内回购部分已发行股份。根据文件显示，公司当日回购普通股7,303,500股，约占已发行股本的0.27%，每股回购价介乎2.03港元至2.08港元，涉资约1502.18万港元。由于该等股份尚未正式注销，公司截至当日收市后的已发行股本总数仍维持在2,705,044,043股。
公告提及，公司于2025年6月26日获得购回授权，授权可购回的股份数量为274,470,604股。截至目前，锦欣生殖已根据该授权累计回购股份119,586,500股，占授权通过当日已发行股本的4.357%。公司确认本次回购已遵守《香港联合交易所证券上市规则》等相关法律法规，且暂止期将持续至2026年7月23日。
本公告由董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.